Cell membrane-camouflaged nanoparticles for drug delivery

被引:489
作者
Luk, Brian T. [1 ]
Zhang, Liangfang [1 ]
机构
[1] Univ Calif San Diego, Dept NanoEngn, Moores Canc Ctr, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
Nanomedicine; Biomimetic nanoparticle; Cell membrane; Drug delivery; Targeted delivery; POLYMER HYBRID NANOPARTICLES; ERYTHROCYTE-MEMBRANE; COATED NANOPARTICLES; TARGETED NANOPARTICLES; IN-VIVO; CLINICAL DEVELOPMENT; BIOMIMETIC DELIVERY; CANCER-CHEMOTHERAPY; COMBINATION THERAPY; BLOCK-COPOLYMERS;
D O I
10.1016/j.jconrel.2015.07.019
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Nanoparticles can preferentially accumulate at sites of action and hold great promise to improve the therapeutic index of many drugs. While conventional methods of nanocarrier-mediated drug delivery have focused on primarily synthetic approaches, engineering strategies that combine synthetic nanoparticles with natural biomaterials have recently gained much attention. In particular, cell membrane-camouflaged nanoparticles are a new class of biomimetic nanoparticles that combine the unique functionalities of cellular membranes and engineering versatility of synthetic nanomaterials for effective delivery of therapeutic agents. Herein, we report on the recent progress on cell membrane-coated nanoparticles for drug delivery. In particular, we highlight three areas: (i) prolonging systemic circulation via cell membrane coating, (ii) cell-specific targeting via cell membrane coating, and (iii) applications of cell membrane coating for drug delivery. The cell membrane-camouflaged nanoparticle platform has emerged as a novel delivery strategy with the potential to improve the therapeutic efficacy for the treatment of a variety of diseases. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:600 / 607
页数:8
相关论文
共 74 条
[1]
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect [J].
Acharya, Sarbari ;
Sahoo, Sanjeeb K. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :170-183
[2]
Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[3]
Aryal S, 2013, NANOMEDICINE-UK, V8, P1271, DOI [10.2217/NNM.12.153, 10.2217/nnm.12.153]
[4]
Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination Therapy [J].
Aryal, Santosh ;
Hu, Che-Ming Jack ;
Zhang, Liangfang .
MOLECULAR PHARMACEUTICS, 2011, 8 (04) :1401-1407
[5]
Combinatorial Drug Conjugation Enables Nanoparticle Dual-Drug Delivery [J].
Aryal, Santosh ;
Hu, Che-Ming Jack ;
Zhang, Liangfang .
SMALL, 2010, 6 (13) :1442-1448
[6]
Polymer-Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery [J].
Aryal, Santosh ;
Hu, Che-Ming Jack ;
Zhang, Liangfang .
ACS NANO, 2010, 4 (01) :251-258
[7]
Biomimetic Delivery with Micro- and Nanoparticles [J].
Balmert, Stephen C. ;
Little, Steven R. .
ADVANCED MATERIALS, 2012, 24 (28) :3757-3778
[8]
Synergistic Targeting of Cell Membrane, Cytoplasm, and Nucleus of Cancer Cells Using Rod-Shaped Nanoparticles [J].
Barua, Sutapa ;
Mitragotri, Samir .
ACS NANO, 2013, 7 (11) :9558-9570
[9]
Particle shape enhances specificity of antibody-displaying nanoparticles [J].
Barua, Sutapa ;
Yoo, Jin-Wook ;
Kolhar, Poornima ;
Wakankar, Aditya ;
Gokarn, Yatin R. ;
Mitragotri, Samir .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (09) :3270-3275
[10]
Gemcitabine and Paclitaxel Every 2 Weeks in Patients With Previously Untreated Urothelial Carcinoma [J].
Calabro, Fabio ;
Lorusso, Vito ;
Rosati, Gerardo ;
Manzione, Luigi ;
Frassineti, Luca ;
Sava, Teodoro ;
Di Paula, Eugenio Donato ;
Alonso, Silvia ;
Sternberg, Cora N. .
CANCER, 2009, 115 (12) :2652-2659